SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-238562
Filing Date
2024-10-17
Accepted
2024-10-17 08:47:59
Documents
19
Period of Report
2024-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d881241d8k.htm   iXBRL 8-K 54365
2 EX-3.1 d881241dex31.htm EX-3.1 21777
3 EX-4.1 d881241dex41.htm EX-4.1 280767
4 EX-99.1 d881241dex991.htm EX-99.1 11622
5 EX-99.2 d881241dex992.htm EX-99.2 9357
9 GRAPHIC g881241g1017092820065.jpg GRAPHIC 2904
10 GRAPHIC g881241g1017093118010.jpg GRAPHIC 2904
  Complete submission text file 0001193125-24-238562.txt   606974

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA kzr-20241017.xsd EX-101.SCH 2878
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20241017_lab.xml EX-101.LAB 18740
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20241017_pre.xml EX-101.PRE 11727
21 EXTRACTED XBRL INSTANCE DOCUMENT d881241d8k_htm.xml XML 3845
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38542 | Film No.: 241376031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)